Are Options Traders Bullish on AERI?
Let daily Option Order Flow show you where stock investors are Bullish and Bearish!!! Receive a FREE daily email of the Market Chameleon Order Flow Sentiment Newsletter.
Market Chameleon

Please Login or Register

Login|Register FREE

Please Login or Register

Login|Register FREE

About AERI

Aerie is a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with glaucoma and other diseases of the eye. Aerie recently reported the successful results of its second Phase 3 registration trial in the United States named Rocket 2, where the primary efficacy endpoint was to demonstrate non-inferiority of IOP lowering for Rhopressa compared to timolol. Rocket 3, a 12-month safety-only study, is currently in progress, and Aerie has recently commenced a fourth Phase 3 trial for Rhopressa, named Rocket 4. Aerie also completed in 2014 a Phase 2b clinical trial in which Roclatan met the primary efficacy endpoint, demonstrating the statistical superiority of Roclatan to each of its components, and recently commenced the first Phase 3 registration trial for Roclatan, named Mercury 1. Aerie also recently announced research collaborations with GrayBug, Inc. and Ramot at Tel Aviv University as it further builds its pipeline for future growth.
Primary Exchange: NASDAQ
SIC Biological Products, (No Diagnostic Substances)
NAICS Pharmaceutical Preparation Manufacturing

AERI is a Holding In These ETFs:

ETF Ticker ETF Name Net Assets Net Assets Raw # Holdings # Holdings Raw Weight Weight Raw Market Value Market Value Raw
BIB ProShares Ultra Nasdaq Biotechnology 294.9 M 2.94941E+08 202 202 0.12% 0.00119191 733 K 732520
EQWS Invesco Russell 2000 Equal Weight ETF 21.1 M 2.11E+07 1,979 1979 0.02% 0.00023 5 K 4914
FHLC Fidelity MSCI Health Care Index ETF 1.6 B 1.6E+09 347 347 0.04% 0.00036285 563 K 562750
IBB iShares Nasdaq Biotechnology Index Fund 8.1 B 8.0755E+09 191 191 0.27% 0.0027 21.3 M 2.13208E+07
IHE iShares U.S. Pharmaceutical ETF 412.4 M 4.1243E+08 47 47 1.1% 0.011 4.5 M 4495050
ITOT iShares Core S&P Total U.S. Stock Market ETF 15.5 B 1.554E+10 3,423 3423 0.01% 0.0001 945 K 944582
IWM iShares Russell 2000 ETF 44.6 B 4.46355E+10 2,024 2024 0.07% 0.0007 32.7 M 3.27111E+07
IWO iShares Russell 2000 Growth ETF 9.3 B 9.28799E+09 1,241 1241 0.15% 0.0015 13.4 M 1.33917E+07
IWV iShares Russell 3000 ETF 8.4 B 8.42237E+09 3,007 3007 0.01% 0.0001 442 K 442028
JKK iShares Morningstar Small-Cap Growth ETF 193.8 M 1.93847E+08 251 251 0.26% 0.0026 493 K 493281
ONEQ Fidelity Nasdaq Composite Index Tracking Stock 1.8 B 1.8E+09 1,029 1029 0.02% 0.000224263 408 K 408245
SBIO ALPS Medical Breakthroughs ETF 226.2 M 2.26151E+08 112 112 1.42% 0.0142 3.2 M 3211344
TILT FlexShares Mornigstar US Market Factors Tilt Index Fund ETF 1.4 B 1.38433E+09 1,905 1905 0.0% 3.8E-05 52 K 52164
UBIO Proshares UltraPro Nasdaq Biotechnology 30.1 M 3.01163E+07 196 196 0.05% 0.000549077 55 K 55036
URTY ProShares UltraPro Russell2000 115.1 M 1.15088E+08 2,034 2034 0.01% 0.00013231 52 K 51789
UWM ProShares Ultra Russell2000 165.6 M 1.65571E+08 2,034 2034 0.03% 0.000304138 108 K 107509
XPH SPDR S&P Pharmaceuticals ETF 303.6 M 3.0356E+08 46 46 2.01% 0.0201481 6.1 M 6068660

Wait, Before You Leave...